| “Sr.No.” | Dosage Form | Generic Name | Composition | Spc. | Qty. | Unit |
|---|---|---|---|---|---|---|
| 01 | Tablets | Nimesulide Tablets (Not to be used for children below 12 years of age) |
Each uncoated tablet contains : Nimesulide Excipients Approved Colour used |
B.P | 100 q.s. | mg |
| 02 | Tablets | Etodolac ER Tablets 400MG | Each film coated extended release tablet contains: | |||
| Etodolac | I.P | 400 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 03 | Tablets | Etodolac and Paracetamol Tablets | Each film coated tablet contains: | |||
| Etodolac | I.P | 400 | mg | |||
| Paracetamol | I.P | 325 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 04 | Tablets | Amisulpiride Tablets I.P 100 mg | Each film coated tablet contains: | |||
| Amisulpride | I.P | 100 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 05 | Tablets | Aceclofenac & Drotaverine HCl Tablets | Each film coated tablet contains : | |||
| Aceclofenac | I.P | 100 | mg | |||
| Drotaverine Hydrochloride | I.P | 80 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 06 | Tablets | Ketoconazole Tablets I.P 200mg | Each film coated tablet contains: | |||
| Ketoconazole | I.P | 200 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 07 | Tablets | Levetiracetam Tablets I.P 500 mg | Each filmcoated tablet contains : | |||
| Levetiracetam | I.P | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 08 | Tablets | Paracetamol, Phenylephrine HCl, Diphenhydramine HCl and Caffeine Tablets | Each uncoated tablet contains : | |||
| Paracetamol | I.P. | 500 | mg | |||
| Phenylephrine Hydrochloride | I.P. | 5 | mg | |||
| Diphenhydramine Hydrochloride | I.P. | 25 | mg | |||
| Caffeine (anhydrous) | I.P. | 30 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 9 | Tablets | Alpha Lipoic Acid, Folic Acid, Methylcobalamin, Pyridoxine HCl and Vitamin D3 Tablets |
Each film coated tablet contains : | |||
| Alpha Lipoic Acid | USP | 100 | mg | |||
| Folic Acid | I.P | 1.5 | mg | |||
| Methylcobalamin | I.P | 1500 | mcg | |||
| Pyridoxine Hydrochloride | I.P | 3 | mg | |||
| Vitamin D3 | I.P | 1000 | IU | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 10 | Tablets | Montelukast and Levocetirizine Tablets I.P | Each film coated tablet contains : | |||
| Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
| Levocetirizine Hydrochloride | I.P. | 5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 11 | Tablets | Etoricoxib and Thiocolchicoside Tablets | Each film coated tablet contains: | |||
| Etoricoxib | I.P. | 60 | mg | |||
| Thiocolchicoside | I.P. | 4 | mg | |||
| Excipients | ||||||
| Approved Colour used | ||||||
| 12 | Tablets | Telmisartan and Amlodipine Besilate Tablets I.P | Each uncoated tablet contains : | |||
| Telmisartan | I.P. | 40 | mg | |||
| Amlodipine Besilate eq.to Amlodipine | I.P. | 5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 13 | Tablets | Aceclofenac and Thiocolchicoside Tablets | Each film coated tablet contains : | |||
| Aceclofenac | I.P. | 100 | mg | |||
| Thiocolchicoside | I.P. | 4 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 14 | Tablets | Aceclofenac and Paracetamol Tablets | Each film coated tablet contains : | |||
| Aceclofenac | I.P. | 100 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 15 | Tablets | “Aceclofenac, Paracetamol and Chlorzoxazone Tablets | Each film coated tablet contains : | |||
| Aceclofenac | I.P. | 100 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| Chlorzoxazone | U.S.P. | 250 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 16 | Tablets | “Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each film coated tablet contains : | |||
| Aceclofenac | I.P. | 100 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| “Serratiopeptidase | I.P. | 15 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 17 | Tablets | “Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each film coated tablet contains : | |||
| Aceclofenac | I.P. | 100 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| “Serratiopeptidase | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 18 | Tablets | Ursodeoxycholic Acid Tablets | Each film coated tablet contains: | |||
| Ursodeoxycholic Acid | I.P | 300 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| Aceclofenac | I.P. | 100 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| Thiocolchicoside | I.P. | 4 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 20 | Tablets | Ferrous Ascorbate, Folic acid and Zinc Sulphate Monohydrate Tablets | Each film coated tablet contains: | |||
| Ferrous ascorbate eq.to elemental iron | 100 | mg | ||||
| Folic Acid | I.P. | 1.5 | mg | |||
| Zinc Sulphate Monohydrate eq. to elemental zinc | I.P. | 22.5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 21 | Tablets | Azithromycin Tablets I.P. | Each film coated tablet contains : | |||
| “Azithromycin Dihydrate | I.P. | 250 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 22 | Tablets | Azithromycin Tablets I.P. | Each film coated tablet contains : | |||
| “Azithromycin Dihydrate | I.P. | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 23 | Tablets | Gabapentin and Methylcobalamin Tablets | Each film coated tablet contains : | |||
| Gabapentin | I.P | 300 | mg | |||
| Methylcobalamin | I.P. | 500 | mcg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 24 | Tablets | Calcium Citrate, Zinc,Vitamin D3 and Magnesium Tablets | Each uncoated tablet contains : | |||
| Calcium Citrate | USP | 1000 | mg | |||
| Zinc Sulphate Monohydrate eq.to elemental Zinc | I.P. | 4 | mg | |||
| Vitamin D3 | I.P. | 200 | IU | |||
| Magnesium Hydroxide eq.to elemental Magnesium | I.P. | 100 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 25 | Tablets | Pregabalin (SR) and Methylcobalamin Tablets | Each uncoated tablet contains: | |||
| Pregabalin (sustained released) | I.P. | 75 | mg | |||
| Methylcobalamin | I.P. | 1500 | mcg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| Appropriate overages of vitamin added to compensate loss on storage. | ||||||
| 26 | Tablets | Ofloxacin Tablets I.P. | Each film coated tablet contains: | |||
| Ofloxacin | I.P. | 200 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 27 | Tablets | “Ferrous Ascorbate, Cyanocobalamin, Folic Acid, Zinc Sulphate Monohydrate Tablets” | Each film coated tablet contains: | |||
| Ferrous Ascorbate | 100 | mg | ||||
| Cyanocobalamin | I.P | 15 | mcg | |||
| Folic Acid | I.P. | 1.5 | mg | |||
| Zinc Sulphate Monohydrate eq. to Elemental Zinc | I.P. | 22.5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 28 | Tablets | Azithromycin & Lactic Acid Bacillus Tablets | Each film coated tablet contains : | |||
| “Azithromycin Dihydrate | I.P. | 500 | mg | |||
| Lactic Acid Bacillus | 6oMillion Spores | |||||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 29 | Tablets | Pregabalin, Nortriptyline & Mecobalamin Tablets | Each film coated tablet contains: | |||
| Pregabalin | I.P | 75 | mg | |||
| Nortriptyline Hydrochloride Eq. to Nortriptyline | I.P | 10 | mg | |||
| Mecobalamin | I.P | 1500 | mcg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 30 | Tablets | Levofloxacin Tablets I.P. 250 mg | Each film coated tablet contains : | |||
| Levofloxacin Hemihydrate eq.to Levofloxacin | I.P. | 250 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 31 | Tablets | Levofloxacin Tablets I.P. 500 mg | Each film coated tablet contains: | |||
| Levofloxacin Hemihydrate eq.to Levofloxacin | I.P. | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 32 | Tablets | Levofloxacin Tablets I.P. 750 mg | Each film coated tablet contains: | |||
| Levofloxacin Hemihydrate eq.to Levofloxacin | I.P. | 750 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 33 | Tablets | Ofloxacin & Ornidazole Tablets I.P | Each film coated tablet contains : | |||
| Ofloxacin | I.P. | 200 | mg | |||
| Ornidazole | I.P. | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 34 | Tablets | Rabeprazole Gastro-resistant Tablets I.P. 20mg | Each enteric coated tablet contains : | |||
| Rabeprazole Sodium | I.P. | 20 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 35 | Tablets | Deflazacort Tablets | Each uncoated tablet contains: | |||
| Deflazacort | 6 | mg | ||||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 36 | Tablets | Deflazacort Tablets | Each uncoated tablet contains: | |||
| Deflazacort | 30 | mg | ||||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 37 | Tablets | Roxithromycin Tablets I.P. 150 mg | Each film coated tablet contains : | |||
| Roxithromycin | I.P. | 150 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 38 | Tablets | “Paracetamol and Nimesulide Tablets | Each uncoated tablet contains : | |||
| Paracetamol | I.P. | 325 | mg | |||
| Nimesulide | B.P. | 100 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 39 | Tablets | “Sildenafil Citrate Tablets | Each film-coated tablet contains : | |||
| Sildenafil Citrate eq.to Sildenafil | I.P. | 100 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| Ondansetron hydrochloride eq. to Ondansetron | I.P. | 4 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 41 | Tablets | Ondansetron Orally Disintegrating Tablets I.P. 8 mg | Each uncoated tablet contains : | |||
| Ondansetron Hydrochloride eq.to Ondansetron | I.P. | 8 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 42 | Tablets | Etoricoxib Tablets I.P 60 mg | Each filmcoated tablet contains: | |||
| Etoricoxib | I.P. | 60 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 43 | Tablets | Etoricoxib Tablets I.P 90 mg | Each film coated tablet contains: | |||
| Etoricoxib | I.P. | 90 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 44 | Tablets | Etoricoxib Tablets I.P 120 mg | Each film coated tablet contains: | |||
| Etoricoxib | I.P. | 120 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 45 | Tablets | Escitalopram Tablets I.P 5 mg | Each film coated tablet contains: | |||
| Escitalopram Oxalate eq.to Escitalopram | I.P. | 5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 46 | Tablets | Escitalopram Tablets I.P 10 mg | Each film coated tablet contains: | |||
| Escitalopram Oxalate eq.to Escitalopram | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 47 | Tablets | Escitalopram Tablets I.P 20 mg | Each film coated tablet contains: | |||
| Escitalopram Oxalate Eq. to Escitalopram | I.P | 20 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 48 | Tablets | Fexofenadine Hydrochloride Tablets I.P. 120 mg | Each film coated tablet contains : | |||
| Fexofenadine Hydrochloride | I.P. | 120 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 49 | Tablets | Fexofenadine Hydrochloride Tablets I.P. 180 mg | Each film coated tablet contains : | |||
| Fexofenadine Hydrochloride | I.P. | 180 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 50 | Tablets | Fexofenadine and Montelukast Tablets | Each chewable film coated tablet contains : | |||
| Fexofenadine Hydrochloride | I.P. | 120 | mg | |||
| Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 51 | Tablets | Atorvastatin Tablets I.P. 10 mg | Each film-coated tablet contains : | |||
| Atorvastatin Calcium eq.to Atorvastatin | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 52 | Tablets | Atorvastatin Tablets I.P. 20 mg | Each film-coated tablet contains : | |||
| Atorvastatin Calcium eq.to Atorvastatin | I.P. | 20 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 53 | Tablets | Atorvastatin Tablets I.P. 40 mg | Each film-coated tablet contains : | |||
| Atorvastatin Calcium eq.to Atorvastatin | I.P. | 40 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 54 | Tablets | Atorvastatin Calcium and Fenofibrate Tablets | Each filmcoated tablet contains: | |||
| “Atorvastatin Calcium | I.P | 10 | mg | |||
| Fenofibrate | I.P | 160 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 55 | Tablets | Atenolol Tablets I.P. 50 mg | Each uncoated tablet contains: | |||
| Atenolol | I.P. | 50 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 56 | Tablets | Atenolol Tablets I.P. 100 mg | Each uncoated tablet contains: | |||
| Atenolol | I.P. | 100 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 57 | Tablets | Methylprednisolone Tablets I.P. 4 mg | Each uncoated tablet contains : | |||
| Methylprednisolone | I.P. | 4 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 58 | Tablets | Methylprednisolone Tablets 8 mg | Each uncoated tablet contains : | |||
| Methylprednisolone | I.P. | 8 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 59 | Tablets | Methylprednisolone Tablets I.P. 16 mg | Each uncoated tablet contains : | |||
| Methylprednisolone | I.P. | 16 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 60 | Tablets | Rosuvastatin Calcium Tablets I.P. 5 mg | Each film coated tablet contains: | |||
| Rosuvastatin Calcium eq.to Rosuvastatin | I.P. | 5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 61 | Tablets | Rosuvastatin Calcium Tablets I.P. 10 mg | Each film coated tablet contains: | |||
| Rosuvastatin Calcium eq.to Rosuvastatin | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 62 | Tablets | Rosuvastatin Calcium Tablets I.P. 20 mg | Each film coated tablet contains: | |||
| Rosuvastatin Calcium eq.to Rosuvastatin | I.P. | 20 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 63 | Tablets | “Rosuvastatin Calcium and Fenofibrate Tablets” | Each film coated tablet contains: | |||
| Rosuvastatin Calcium eq.to Rosuvastatin | I.P. | 10 | mg | |||
| Fenofibrate | I.P | 160 | mg | |||
| Excipients | q.s. | |||||
| Colour: | ||||||
| 64 | Tablets | Duloxetine Hydrochloride Tablets 20mg | Each enteric coated tablet contains: | |||
| Duloxetine Hydrochloride eq.to Duloxetine | I.P | 20 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 65 | Tablets | Duloxetine Hydrochloride Tablets 30 mg | Each enteric coated tablet contains: | |||
| Duloxetine Hydrochloride eq.to Duloxetine | I.P | 30 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 66 | Tablets | Telmisartan Tablets I.P. 20 mg | Each uncoated tablet contains : | |||
| Telmisartan | I.P. | 20 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 67 | Tablets | Telmisartan Tablets I.P. 40 mg | Each uncoated tablet contains : | |||
| Telmisartan | I.P. | 40 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 68 | Tablets | Telmisartan Tablets I.P. 80 mg | Each uncoated tablet contains : | |||
| Telmisartan | I.P. | 80 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 69 | Tablets | Telmisartan 40 mg and Hydrochlorothiazide 12.5 mg Tablets I.P. | Each film coated tablet contains: | |||
| Telmisartan | I.P. | 40 | mg | |||
| Hydrochlorothiazide | I.P. | 12.5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 70 | Tablets | Telmisartan 80 mg and Hydrochlorothiazide 12.5 mg Tablets I.P | Each film coated tablet contains: | |||
| Telmisartan | I.P. | 80 | mg | |||
| Hydrochlorothiazide | I.P. | 12.5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 71 | Tablets | Telmisartan and Metoprolol Succinate (ER) Tablets | Each filmcoated tablet contains: | |||
| Telmisartan | I.P | 40 | mg | |||
| Metoprolol Succinate eq.to Metoprolol Tartrate (Extended Released) | I.P. | “47.550” | ||||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 72 | Tablets | Telmisartan, Amlodipine and Hydrochlorothiazide Tablets | Each uncoated tablet contains: | |||
| Telmisartan | I.P. | 40 | mg | |||
| “Amlodipine Besylate eq.to Amlodipine” | I.P. | 5 | mg | |||
| Hydrochlorothiazide | I.P. | 12.5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 73 | Tablets | Divalproex Extended Release Tablets I.P 250mg | Each film coated extended release tablet contain: | |||
| Divalproex Sodium Eq. to Valproic Acid | I.P | 250 | mg | |||
| Excipients | q.s | |||||
| Approved Colour used | ||||||
| 74 | Tablets | Divalproex Extended Release Tablets I.P 500mg | Each film coated extended release tablet contain: | |||
| Divalproex Sodium Eq. to Valproic Acid | I.P | 500 | mg | |||
| Excipients | q.s | |||||
| Approved Colour used | ||||||
| 75 | Tablets | “Divalproex Extended Release Tablets I.P 1000mg” | Each film coated extended release tablet contain: | |||
| Divalproex Sodium Eq. to Valproic Acid | I.P | 1000 | mg | |||
| Excipients | q.s | |||||
| Approved Colour used | ||||||
| 76 | Tablets | Pantoprazole Gastro-resistant Tablets I.P. 40 mg | Each enteric-coated tablet contains: | |||
| Pantoprazole Sodium eq.to Pantoprazole | I.P. | 40 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 77 | Tablets | Cetirizine Hydrochloride Tablets I.P. 10 mg | Each uncoated tablet contains : | |||
| Cetirizine Hydrochloride | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 78 | Tablets | Levocetirizine Tablets I.P. 5 mg | Each uncoated tablet contains : | |||
| Levocetirizine Hydrochloride | I.P. | 5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 79 | Tablets | Betahistine Hydrochloride Tablets I.P. | Each film coated tablet contains : | |||
| Betahistine Hydrochloride | I.P. | 16 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 80 | Tablets | Betahistine Hydrochloride Tablets I.P. | Each film coated tablet contains: | |||
| Betahistine Hydrochloride | I.P. | 8 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 81 | Tablets | Paracetamol Tablets I.P. 650 mg | Each uncoated tablet contains : | |||
| Paracetamol | I.P. | 650 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 82 | Tablets | “Serratiopeptidase Tablets I.P. 10 mg” | Each enteric coated tablet contains : | |||
| “Serratiopeptidase | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 83 | Tablets | Febuxostat Tablets 40 mg | Each film coated tablet contains: | |||
| Febuxostat | 40 | mg | ||||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 84 | Tablets | Febuxostat Tablets 80 mg | Each film coated tablet contains: | |||
| Febuxostat | 80 | mg | ||||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 85 | Tablets | Voglibose Tablets I.P. 0.2 mg | Each uncoated tablet contains : | |||
| Voglibose | I.P. | 0.2 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 86 | Tablets | Voglibose Tablets I.P. 0.3 mg | Each uncoated tablet contains : | |||
| Voglibose | I.P. | 0.3 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 87 | Tablets | Hydroxyzine Tablets I.P. 10 mg | Each uncoated tablet contains: | |||
| Hydroxyzine Hydrochloride | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 88 | Tablets | Hydroxyzine Tablets I.P. 25 mg | Each uncoated tablet contains: | |||
| Hydroxyzine Hydrochloride | I.P. | 25 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 89 | Tablets | Citicoline Tablets I.P 500 mg | Each film coated tablet contains: | |||
| Citicoline Sodium eq.to Citicoline | I.P. | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 90 | Tablets | Loratadine Tablets I.P. | Each uncoated tablet contains: | |||
| Loratadine | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 91 | Tablets | Olmesartan Medoxomil Tablets I.P. 20 mg | Each film coated tablet contains: | |||
| Olmesartan Medoxomil | I.P. | 20 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 92 | Tablets | Olmesartan Medoxomil Tablets I.P. 40 mg | Each film coated tablet contains: | |||
| Olmesartan Medoxomil | I.P. | 40 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 93 | Tablets | “Olmesartan Medoxomil 20 mg and Hydrochlorothiazide 12.5 mg Tablets I.P” | Each uncoated tablet contains: | |||
| Olmesartan Medoxomil | I.P | 20 | mg | |||
| Hydrochlorothiazide | I.P | 12.5 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 94 | Tablets | Olmesartan Medoxomil and Amlodipine Tablets | Each uncoated tablet contains: | |||
| Olmesartan Medoxomil | I.P | 40 | mg | |||
| Amlodipine Besylate eq.to Amlodipine | I.P. | 5 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 95 | Tablets | Linezolid Tablets I.P. | Each film coated tablet contains: | |||
| Linezolid | I.P. | 600 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 96 | Tablets | Losartan Potassium Tablets I.P. 50 mg | Each film coated tablet contains: | |||
| Losartan Potassium | I.P. | 50 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 97 | Tablets | Losartan Potassium and Amlodipine Tablets I.P. | Each film coated tablet contains: | |||
| Losartan Potassium | I.P. | 50 | mg | |||
| Amlodipine Besilate eq.to Amlodipine | I.P. | 5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 98 | Tablets | Losartan Potassium and Hydrochlorothiazide Tablets I.P. | Each film coated tablet contains: | |||
| Losartan Potassium | I.P. | 50 | mg | |||
| Hydrochlorothiazide | I.P. | 12.5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 99 | Tablets | Metformin Hydrochloride Sustained Released Tablets I.P. | Each uncoated tablet contains: | |||
| Metformin Hydrochloride (sustained released) | I.P. | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 100 | Tablets | Amlodipine Besilate Tablets I.P. | Each film coated tablet contains: | |||
| Amlodipine Besilate eq.to Amlodipine | I.P. | 5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 101 | Tablets | “Amlodipine Besilate and Atenolol Tablets I.P.” | Each uncoated tablet contains: | |||
| Amlodipine Besilate eq.to Amlodipine | I.P. | 5 | mg | |||
| Atenolol | I.P. | 50 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 102 | Tablets | Amlodipine Besylate and Metoprolol Succinate (ER)Tablets | Each uncoated tablet contains: | |||
| Amlodipine Besylate Eq.to Amlodipine | I.P. | 5 | mg | |||
| Metoprolol Succinate eq.to Metoprolol Tartrate (Extended Released) | I.P. I.P | “47.50” | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 103 | Tablets | “Diclofenac Sodium and Paracetamol Tablets I.P | Each uncoated tablet contains : | |||
| Diclofenac Sodium | I.P. | 50 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 104 | Tablets | Mefenamic Acid and Dicyclomine HCl Tablets I.P | Each uncoated tablet contains : | |||
| Mefenamic Acid | I.P. | 250 | mg | |||
| Dicyclomine Hydrochloride | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 105 | Tablets | Metoprolol Succinate (ER) Tablets I.P. | Each film coated tablet contains: | |||
| Metoprolol Succinate eq.to Metoprolol Tartrate (extended released) | I.P. I.P | “23.7525” | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 106 | Tablets | Metoprolol Succinate (ER) Tablets I.P. | Each film coated tablet contains: | |||
| Metoprolol Succinate eq.to Metoprolol Tartrate (extended released) | “I.P.” | “47.50” | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 107 | Tablets | Lornoxicam and Paracetamol Tablets | Each film coated tablet contains : | |||
| Lornoxicam | 4 | mg | ||||
| Paracetamol | I.P. | 325 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 108 | Tablets | Lornoxicam and Paracetamol Tablets | Each film coated tablet contains: | |||
| Lornoxicam | 8 | mg | ||||
| Paracetamol | I.P. | 325 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 109 | Tablets | Aceclofenac Sustained Released Tablets 200mg | Each uncoated sustained released tablet contains : | |||
| Aceclofenac | I.P. | 200 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 110 | Tablets | Montelukast and Levocetirizine Hydrochloride Tablets I.P | Each film coated tablet contains : | |||
| Levocetirizine Hydrochloride | I.P. | 2.5 | mg | |||
| Montelukast Sodium eq.to Montelukast | I.P. | 4 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 111 | Tablets | Glucosamine, Methylsulphonylmethane and Diacerein Tablets | Each film coated tablet contains : | |||
| “Glucosamine Sulphate Potassium Chloride | USP | “750/446” | mg | |||
| Methylsulphonylmethane | USP | 250 | mg | |||
| Diacerein | I.P. | 50 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 112 | Tablets | Diclofenac Sodium and Serratiopeptidase Tablets | Each enteric coated tablet contains : | |||
| Diclofenac Sodium | B.P. | 50 | mg | |||
| “Serratiopeptidase | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 113 | Tablets | Etoricoxib and Paracetamol Tablets | Each film coated tablet contains: | |||
| Etoricoxib | I.P. | 60 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 114 | Tablets | Tranexamic Acid and Mefenamic Acid Tablets | Each film coated tablet contains : | |||
| Tranexamic Acid | I.P. | 500 | mg | |||
| Mefenamic Acid | I.P. | 250 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 115 | Tablets | Levocetirizine Hydrochloride and Ambroxol Hydrochloride (SR) Tablets | Each uncoated sustained released tablet contains : | |||
| Levocetirizine Hydrochloride | I.P. | 5 | mg | |||
| Ambroxol Hydrochloride (as sustained released) | I.P. | 75 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 116 | Tablets | Aceclofenac and Thiocolchicoside Tablets | Each film coated tablet contains : | |||
| Aceclofenac | I.P. | 100 | mg | |||
| Thiocolchicoside | I.P. | 8 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 117 | Tablets | Trypsin,Bromelain and Rustoside Trihydrate Tablets | Each enteric coated tablet contains : | |||
| Trypsin | B.P. | 48 | mg | |||
| Bromelain | 90 | mg | ||||
| Rustoside Trihydrate | B.P. | 100 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 118 | Tablets | Trypsin,Bromelain, Rustoside Trihydrate and Diclofenac Sodium Tablets | Each enteric coated tablet contains : | |||
| Trypsin | B.P. | 48 | mg | |||
| Bromelain | 90 | mg | ||||
| Rustoside Trihydrate | B.P. | 100 | mg | |||
| Diclofenac Sodium | I.P. | 50 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 119 | Tablets | Terbinafine Tablets I.P 250 mg | Each uncoated tablet contains: | |||
| Terbinafine Hydrochloride eq.to Terbinafine | I.P | 250 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 120 | Tablets | Levosulpride Tablets | Each film coated tablet contains: | |||
| Levosulpride | 50 | mg | ||||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 121 | Tablets | Eperisone Hydrochloride and Paracetamol Tablets | Each film coated tablet contains: | |||
| Eperisone Hydrochloride | 50 | mg | ||||
| Paracetamol | I.P. | 325 | mg | |||
| Excipients | ||||||
| Approved Colour used | ||||||
| 122 | Tablets | Cinnarizine and Domperidone Tablets | Each uncoated tablet contains: | |||
| Cinnarizine | I.P. | 20 | mg | |||
| Domperidone | I.P. | 15 | mg | |||
| Excipients | ||||||
| Approved Colour used | ||||||
| 123 | Tablets | Tolperisone HCl and Diclofenac Sodium Tablets | Each uncoated tablet contains: | |||
| Tolperisone Hydrochloride | 150 | mg | ||||
| Diclofenac Sodium | I.P. | 50 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 124 | Tablets | “Sildenafil Citrate Tablets I.P. 50 mg” | Each film-coated tablet contains : | |||
| Sildenafil Citrate eq.to Sildenafil | I.P. | 50 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 125 | Tablets | Amisulpiride Tablets IP 50 mg | Each film coated tablet contains: | |||
| Amisulpride | I.P | 50 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 126 | Tablets | Ketoconazole Tablets I.P 200mg | Each film coated tablet contains: | |||
| Ketoconazole | I.P | 200 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 127 | Tablets | Ketorolac Tromethamine Dispersible Tablets 10mg | Each uncoated dispersible tablet contains : | |||
| Ketorolac Tromethamine | I.P | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 128 | Tablets | Drotaverine Hydrochloride and Mefenamic Acid Tablets | Each film coated tablet contains : | |||
| Drotaverine Hydrochloride | I.P | 80 | mg | |||
| Mefenamic Acid | I.P. | 250 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 129 | Tablets | Citicoline and Piracetam Tablets | Each film coated tablet contains: | |||
| Citicoline Sodium eq.to Citicoline | I.P. | 500 | mg | |||
| Piracetam | I.P. | 400 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 130 | Tablets | Metformin HCl Prolonged release and Glimepiride Tablets I.P | Each uncoated bilayred tablet contains: | |||
| Metformin Hydrochloride (In Prolonged release form) | I.P. | 500 | mg | |||
| Glimepiride | I.P. | 1 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 131 | Tablets | Metformin HCl Prolonged release and Glimepiride Tablets I.P | Each uncoated bilayred tablet contains: | |||
| Metformin Hydrochloride (In Prolonged release form) | I.P. | 500 | mg | |||
| Glimepiride | I.P. | 2 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 132 | Tablets | Vildagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: | |||
| Vildagliptin | I.P | 50 | mg | |||
| Metformin Hydrochloride | I.P. | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 133 | Tablets | Vildagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: | |||
| Vildagliptin | I.P | 50 | mg | |||
| Metformin Hydrochloride | I.P. | 850 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 134 | Tablets | Vildagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: | |||
| Vildagliptin | I.P | 50 | mg | |||
| Metformin Hydrochloride | I.P. | 1000 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 135 | Tablets | “Tamsulosin HCl (MR) and Dutasteride Tablets” | Each film coated tablet contains: | |||
| Tamsulosin Hydrochloride (as modified release) | I.P | 0.4 | mg | |||
| Dutasteride | I.P | 0.5 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 136 | Tablets | Levetiracetam Tablets I.P | Each film coated tablet contains: | |||
| Levetiracetam | I.P | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 137 | Tablets | Fexofenadine and Montelukast Chewable Tablets | Each uncoated chewable tablet contains : | |||
| Fexofenadine Hydrochloride | I.P. | 120 | mg | |||
| Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 138 | Tablets | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: | |||
| Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin | I.P | 50 | mg | |||
| Metformin Hydrochloride | I.P. | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 139 | Tablets | Flupentixol and Melitracen Tablets | Each film coated tablet contains: | |||
| Flupentixol Hydrochloride Eq. to Flupentixol | B.P | 0.5 | mg | |||
| Melitracen Hydrochloride Eq to Melitracen | 10 | mg | ||||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 140 | Tablets | Combipack of Mifepristone and Misoprostol Tablets | Each pack contains: | |||
| A} 1 Mifepristone Tablets I.P | ||||||
| Each uncoated tablet contains: | ||||||
| Mifepristone | I.P | 200 | mg | |||
| Excipients | q.s | |||||
| B} 4 Misoprostol Tablets I.P | ||||||
| Each uncoated tablet contains: | ||||||
| Misoprostol | I.P | 200 | mcg | |||
| Excipients | q.s. | |||||
| 141 | Tablets | Paracetamol, Phenylephrine HCl and Cetirizine HCl Tablets | Each uncoated tablet contains: | |||
| Paracetamol | I.P | 325 | mg | |||
| Phenylephrine Hydrochloride | I.P | 5 | mg | |||
| Cetirizine Hydrochloride | I.P | 5 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 142 | Tablets | Teneligliptin and Metformin Hydrochloride (ER)Tablets | Each uncoated bilayered tablet contains: | |||
| Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin | I.P | 20 | mg | |||
| Metformin Hydrochloride (as extended release) | I.P. | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 143 | Tablets | Naproxen and Domperidone Tablets | Each film coated tablet contains: | |||
| Naproxen | I.P | 500 | mg | |||
| Domperidone | I.P | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 144 | Tablets | Levocetirizine Dihydrochloride, Montelukast and Ambroxol HCl (SR) Tablets | Each film coated tablet contains : | |||
| Levocetirizine Dihydrochloride | I.P. | 5 | mg | |||
| Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
| Ambroxol Hydrochloride (as sustained release) | I.P | 75 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 145 | Tablets | Acebrophylline Sustained Release, Fexofenadine HCl and Montelukast Tablets | Each film coated tablet contains : | |||
| “Acebrophylline | 200 | mg | ||||
| Fexofenadine Hydrochloride | I.P. | 120 | mg | |||
| Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 146 | Tablets | Ferrous Ascorbate, Folic acid and Zinc Sulphate Monohydrate Tablets | Each film coated tablet contains: | |||
| Ferrous Ascorbate | I.P | 100 | mg | |||
| Folic Acid | I.P. | 1.5 | mg | |||
| Zinc Sulphate Monohydrate eq. to elemental zinc | I.P. | 22.5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 147 | Tablets | “Aceclofenac, Paracetamol,Cetirizine Dihydrochloride, Phenylephrine HCl and CaffeineTablets | Each uncoated tablet contains : | |||
| Aceclofenac | I.P. | 100 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| Cetirizine Dihydrochloride | I.P | 10 | mg | |||
| Phenylephrine Hydrochloride | I.P | 5 | mg | |||
| Caffeine | I.P. | 25 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 147 | Tablets | Doxylamine Succinate, Pyridoxine HCl & Folic Acid Tablets | Each enteric coated tablet contains : | |||
| Doxylamine Succinate | USP | 10 | mg | |||
| Pyridoxine Hydrochloride | I.P. | 10 | mg | |||
| Folic Acid | I.P | 2.5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 148 | Tablets | Rabeprazole and Ondansetron Tablets | Each enteric coated tablet contains : | |||
| Rabeprazole Sodium | I.P. | 20 | mg | |||
| “Ondansetron Hydrochloride | I.P. | 4 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 149 | Tablets | Diclofenac Potassium and Serratiopeptidase Tablets | Each enteric coated tablet contains : | |||
| Diclofenac Pottasium | B.P. | 50 | mg | |||
| “Serratiopeptidase | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 150 | Tablets | “Glimepiride, MetforminHCl (SR) and Pioglitazone Tablets | Each uncoated bilayered tablet contains: | |||
| Glimepiride | I.P. | 2 | mg | |||
| Metformin Hydrochloride (In sustained release form) | I.P. | 500 | mg | |||
| Pioglitazone Hydrochloride eq. to Pioglitazone | I.P | 15 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 151 | Tablets | “Glimepiride, Metformin HCl (SR) and Pioglitazone Tablets |
Each uncoated bilayered tablet contains: | |||
| Glimepiride | I.P. | 1 | mg | |||
| Metformin Hydrochloride (In sustained release form) | I.P. | 500 | mg | |||
| Pioglitazone Hydrochloride eq. to Pioglitazone | I.P | 15 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 152 | Tablets | “Diclofenac Potassium Paracetamol and Serratiopeptidase Tablets | Each film coated tablets contains : | |||
| Diclofenac Potassium | B.P | 50 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| “Serratiopeptidase | I.P | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 153 | Tablets | Metoprolol Succinate (ER) Tablets I.P. | Each uncoated extended release tablet contains: | |||
| Metoprolol Succinate eq.to Metoprolol Tartrate (extended released) | I.P | “23.7525” | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 154 | Tablets | Metoprolol Succinate (ER) Tablets I.P. | Each uncoated extended release tablet contains: | |||
| Metoprolol Succinate eq.to Metoprolol Tartrate (extended released) | “I.P. | “47.50 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 155 | Tablets | Telmisartan 80 mg and Chlorthalidone 12.5 mg Tablets | Each film coated tablet contains: | |||
| Telmisartan | I.P. | 80 | mg | |||
| Chlorthalidone | I.P. | 12.5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 156 | Tablets | Telmisartan 40 mg and Chlorthalidone 12.5 mg Tablets | Each film coated tablet contains: | |||
| Telmisartan | I.P. | 40 | mg | |||
| Chlorthalidone | I.P. | 12.5 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 157 | Tablets | Fexofenadine and Montelukast Tablets | Each film coated tablet contains : | |||
| Fexofenadine Hydrochloride | I.P. | 120 | mg | |||
| Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 158 | Tablets | Aceclofenac and Paracetamol Tablets | Each uncoated tablet contains : | |||
| Aceclofenac | I.P. | 100 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 159 | Tablets | Lansoprazole Orally Disintegrating Tablets | Each uncoated tablet contains : | |||
| “Lansoprazole | I.P. | 15 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 160 | Tablets | Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Tablets | Each uncoated tablet contains : | |||
| Dextromethorphan Hydrobromide | I.P. | 10 | mg | |||
| Chlorpheniramine Maleate | I.P. | 2 | mg | |||
| Phenylepherine Hydrochloride | I.P. | 5 | mg | |||
| Excipients | q.s. | |||||
| Colour: Ponceau-4R | ||||||
| 161 | Tablets | Metformin Hydrochloride Sustained Released Tablets I.P. | Each uncoated sustained release tablet contains: | |||
| Metformin Hydrochloride | I.P. | 1000 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 162 | Tablets | Rosuvastatin Calcium Tablets I.P. 40 mg | Each film coated tablet contains: | |||
| Rosuvastatin Calcium eq.to Rosuvastatin | I.P. | 40 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 163 | Tablets | Citicoline and Piracetam Tablets | Each film coated tablet contains: | |||
| Citicoline Sodium eq.to Citicoline | I.P. | 500 | mg | |||
| Piracetam | I.P. | 800 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 164 | Tablets | Aceclofenac & Drotaverine HCl Tablets | Each film coated tablet contains: | |||
| Aceclofenac | I.P. | 100 | mg | |||
| Drotaverine Hydrochloride | I.P. | 80 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 165 | Tablets | Aceclofenac, Paracetamol and Thiocolchicoside Tablets | Each film coated tablet contains: | |||
| Aceclofenac | I.P. | 100 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| Thiocolchicoside | I.P. | 4 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 166 | Tablets | Ondansetron Orally Disintegrating Tablets I.P. 4 mg | Each uncoated tablet contains : | |||
| Ondansetron hydrochloride | I.P. | 4 | mg | |||
| eq. to Ondansetron | q.s. | |||||
| Approved Colour used | ||||||
| 167 | Tablets | Pantoprazole and Domperidone Tablets | Each enteric coated tablet contains: | |||
| Pantoprazole Sodium eq.to Pantoprazole | I.P. | 40 | mg | |||
| Domperidone | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 168 | Tablets | Rabeprazole and Domperidone Tablets | Each enteric coated tablet contains: | |||
| Rabeprazole Sodium | I.P. | 20 | mg | |||
| Domperidone | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 169 | Tablets | Gabapentin & Nortriptyline HCl Tablets | Each enteric coated tablet contains: | |||
| Gabapentin | I.P. | 400 | mg | |||
| Nortriptyline Hydrochloride Eq. to Nortriptyline | I.P. | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 170 | Tablets | Diclofenac Potassium Paracetamol and Chlorzoxazone Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
Each enteric coated tablet contains: | |||
| Diclofenac Potassium | B.P | 50 | mg | |||
| Paracetamol | I.P. | 325 | mg | |||
| Chlorzoxazone | USP | 250 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 171 | Tablets | Glimepiride and Metformin Hydrochloride (SR) Tablets | Each uncoated bilayered tablet contains: | |||
| Glimepiride | I.P. | 2 | mg | |||
| Metformin Hydrochloride (sustained released) |
I.P. | 1000 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 172 | Tablets | Trypsin,Bromelain, Rustoside Trihydrate and Aceclofenac Tablets | Each enteric coated tablet contains : | |||
| Trypsin | B.P. | 48 | mg | |||
| Bromelain | 90 | mg | ||||
| Rustoside Trihydrate | B.P | 100 | mg | |||
| Aceclofenac | I.P. | 100 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 173 | Tablets | Esomeprazole Gastro-resistant Tablets I.P 20mg | Each enteric coated tablet contains : | |||
| Each enteric coated tablet contains : | I.P. | 20 | mg | |||
| Excipients | q.s. | |||||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 174 | Tablets | Esomeprazole Gastro-resistant Tablets I.P 40mg | Each enteric coated tablet contains : | |||
| Esomeprazole Magnesium Trihydrate eq.to Esomeprazole | I.P. | 40 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 175 | Tablets | Methylcobalamin,L-Methyl Folate & Pyridoxal-5 Phosphate Tablets | Each film coated tablet contains: | |||
| Methylcobalamin | I.P. | 1500 | mg | |||
| L-5 Methyltetrahydrofolate Calcium eq. to L-Methyl Folate | 1 | mg | ||||
| Pyridoxal-5 Phosphate | 0.5 | mg | ||||
| Excipients | 0.5 | mg | ||||
| Approved colour used | ||||||
| 176 | Tablets | Methylcobalamin, Folic acid, Vitamin B6, Pregabalin & Benfothaimine Capsules | Each hard gelatin capsules contains : | |||
| Methylcobalamin | I.P. | 750 | mcg | |||
| Folic Acid | I.P | 0.75 | mg | |||
| Vitamin B6 | I.P | 1.5 | mg | |||
| Pregabalin | IP | 75 | mg | |||
| Benfothiamine | I.P | 7.5 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used in capsules shells. | ||||||
| 177 | Tablets | Ginkgo biloba Dry Extract Tablets I.P | Each film coated tablet contains : | |||
| Ginkgo biloba dry extract (containing of 9.6mg of ginkgo flavone glycosides) |
I.P. | 40 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 178 | Tablets | L-Carnitine L-Tartrate, Methylcobalamin & Folic Acid Tablets |
Each film coated tablet contains : | |||
| L-Carnitine L-Tartrate Eq. to L-Carnitine |
500 | mg | ||||
| Methylcobalamin | IP | 1500 | mcg | |||
| Folic Acid | x | 1.5 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 179 | Tablets | Telmisartan 40 mg & Cilnidipine 10 mg Tablets |
Each film coated tablet contains: | |||
| Telmisartan | IP | 40 | mg | |||
| Cilnidipine | IP | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used | ||||||
| 180 | Tablets | Flavoxate Hydrochloride Tablets I.P 200mg |
Each film coated tablet contains: | |||
| Flavoxate Hydrochloride | IP | 200 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 181 | Tablets | Amitriptyline Hydrochloride Tablets I.P | Each film coated tablet contains: | |||
| Amitriptyline Hydrochloride Tablets I.P | IP | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 182 | Tablets | Amitriptyline Hydrochloride Tablets I.P | Each film coated tablet contains: | |||
| Amitriptyline Hydrochloride Tablets I.P | IP | 25 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 183 | Tablets | Amitriptyline Hydrochloride Tablets I.P | Each film coated tablet contains: | |||
| Amitriptyline Hydrochloride Tablets I.P | IP | 50 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 184 | Tablets | Voglibose and Metformin Hydrochloride (SR) Tablets | Each uncoated bilayered tablet contains: | |||
| Voglibose | IP | 0.3 | mg | |||
| Metformin Hydrochloride (sustained released) |
I.p | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | ||||||
| 185 | Tablets | Gabapentin Tablets I.P 100 mg |
Each film coated tablet contains: | |||
| Gabapentin | IP | 100 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | q.s. | |||||
| 186 | Tablets | Gabapentin Tablets I.P 300 mg |
Each film coated tablet contains: | |||
| Gabapentin | IP | 300 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | q.s. | |||||
| 187 | Tablets | Drotaverine Hydrochloride Tablets I.P 40mg | Each film coated tablet contains: | |||
| Drotaverine Hydrochloride | IP | 40 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | q.s. | |||||
| 188 | Tablets | Tadalafil Tablets I.P 10mg |
Each film coated tablet contains : | |||
| Tadalafil | IP | 10 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | q.s. | |||||
| 189 | Tablets | Propranolol Hydrochloride Tablets I.P 40mg | Each uncoated tablet contains : | |||
| Propranolol Hydrochloride | IP | 40 | mg | |||
| Excipients | q.s. | |||||
| Approved Colour used | q.s. | |||||
| 190 | Tablets | Bilastine and Montelukast Tablets | Each filmcoated tablet contains : | |||
| Each filmcoated tablet contains : | IP | 20 | mg | |||
| Montelukast Sodium Eq. to Montelukast |
10 | |||||
| Excipients | q.s. | |||||
| Approved Colour used |